1.Analysis of risk factors for cardiovascular events and construction of a nomogram prediction model in patients undergoing long-term peritoneal dialysis
Xinyuan ZHOU ; Yuxin JIANG ; Xiaoxia WANG ; Xiangjie YANG ; Runzhe ZHOU ; Yuqing MENG ; Dingxin ZHANG ; Jin ZHANG ; Ying WANG
Acta Universitatis Medicinalis Anhui 2026;61(4):748-757
ObjectiveTo analyze the risk factors for long-term cardiovascular events in patients undergoing long-term peritoneal dialysis (PD), and to construct and validate a visual nomogram prediction model based on multiple parameters. MethodsA prospective cohort study was conducted, consecutively enrolling 248 maintenance PD patients (dialysis duration ≥ 3 months). Demographic characteristics, clinical indicators, laboratory parameters, and echocardiographic indices (including left ventricular ejection fraction [LVEF], ratio of early diastolic mitral inflow velocity to early diastolic mitral annular velocity (E/e’), etc.) were collected. The composite endpoint was defined as the occurrence of cardiovascular events or cardiovascular death, with non-cardiovascular death as the competing risk and loss to follow-up or the end of follow-up as censoring events. Fine-Gray competing risks model was used to screen independent predictors, based on which a nomogram model was constructed. Internal validation was performed using the Bootstrap method (1 000 resamplings), and the concordance index (C-index) and time-dependent receiver operating characteristic (time-dependent ROC) curve were calculated to evaluate the model performance. ResultsWith a median follow-up of 29 months (interquartile range: 24–35 months), 88 patients (35.48%) reached the composite endpoint, including 80 cases of cardiovascular events and 8 cases of cardiovascular death, and 4 patients died of non-cardiovascular causes. Multivariate Fine-Gray analysis revealed that age, diabetes mellitus, hemoglobin (HGB) level and E/e' ratio were independent influencing factors of the composite endpoint. Specifically, each 1-year increase in age was associated with a 3.0% increase in the risk of the composite endpoint (HR=1.030, P=0.006); patients with diabetes mellitus had a 167.9% higher risk compared with non-diabetic patients (HR=2.679, P=0.007); each 1g/L increase in HGB level contributed to a 1.5% reduction in the risk (HR=0.985, P=0.003); and each 0.1 increase in E/e' ratio led to a 7.2% increase in the risk (HR=1.072, P=0.045). The nomogram model had a C-index of 0.76 (95% CI: 0.698–0.820), and the AUC of the time-dependent ROC curve reached 0.849 at 23 months of follow-up. ConclusionIncreased age, complicated with diabetes mellitus, decreased HGB, and elevated E/e' ratio are independent risk factors of long-term occurrence of cardiovascular events and cardiovascular death in patients undergoing long-term PD. The nomogram model constructed based on the above variables has good predictive value and clinical applicability, which can provide a reference for cardiovascular risk stratification and individualized intervention in long-term PD patients.
2.Association of the adipokine Chemerin with the development and progression of liver fibrosis
Xinyuan ZHANG ; Nuoqi ZHANG ; Guohui YU ; Wenshuai REN ; Yaling WANG
Journal of Clinical Hepatology 2025;41(1):164-169
Liver fibrosis is the common pathological process in the progression of various chronic liver diseases to liver cirrhosis, and it greatly affects the prognosis of patients with chronic liver diseases. As a novel adipokine, Chemerin participates in the metabolism of glucose and lipids and inflammation, and various studies have shown that the expression level of Chemerin is correlated with the degree of liver fibrosis, suggesting that Chemerin may be involved in the process of liver fibrosis by regulating metabolism and inflammation. Chemerin has shown certain potential in the auxiliary diagnosis of liver fibrosis and the intervention against the progression of liver fibrosis. This article reviews the potential role and mechanism of action of Chemerin in the process of liver fibrosis, in order to provide new ideas for the diagnosis and treatment of liver fibrosis.
3.Evaluation of dietary intervention in patients with hypertensive nephropathy
WANG Qikai ; MI Yanan ; LIU Hao ; LIN Jiahao ; YANG Xinyuan ; WANG Yue ; JIN Qianjing ; SONG Zhaomeng
Journal of Preventive Medicine 2025;37(4):373-377
Objective:
To evaluate the effects of dietary intervention on blood pressure and renal function in patients with hypertensive nephropathy, so as to provide dietary and nutritional guidances for this population.
Methods:
Hypertensive nephropathy patients who were treated at Zhucheng People's Hospital from March 2023 to February 2024 were selected as the study subjects and randomly divided into the intervention group and the control group. The control group received routine antihypertensive treatment and health lifestyle guidance. On the basis of the treatment and guidance received by the control group, the intervention group implemented dietary intervention in accordance with the Clinical Practice Guidelines for Nutritional Therapy of Chronic Kidney Disease in China (2021 edition) for a period of 3 months. Systolic blood pressure (SBP), diastolic blood pressure (DBP) were measured before and after the intervention, and serum creatinine (Scr), blood urea nitrogen (BUN), uric acid (UA), cystatin and β2-microglobulin were detected. Differences of indicators before and after intervention between the two groups were compared using generalized estimation equation.
Results:
A total of 83 patients with hypertensive nephropathy were followed up, including 43 cases in the intervention group and 40 cases in the control group. There were no statistically significant differences in gender, age, body mass index, duration of hypertension, family history of hypertension, hypertension grade, physical activity index, or smoking status between the two groups (all P>0.05). The differences in SBP, DBP, Scr, BUN, and UA between the two groups, as well as the differences before and after the intervention, were statistically significant, and there was an interaction between the groups and the intervention time (all P<0.05). After intervention, the levels of SBP, DBP, Scr, BUN, and UA in the intervention group were lower than those in the control group (all P<0.05). The differences in cystatin and β2-microglobulin between the two groups and before and after the intervention were not statistically significant, and there was no interaction between the groups and the intervention time (all P>0.05).
Conclusion
Dietary intervention has a certain effect on reducing blood pressure and improving renal function indicators in patients with hypertensive nephropathy.
4.Study on the inhibitory effect and mechanism of Modified qifang weitong granules on gastric cancer
Xinyuan CHEN ; Chengting WU ; Changzhou XIONG ; Ting WANG ; Yinhang CUI ; Peibin WU ; Wenlong CHEN ; Huilin CHEN ; Caizhi LIN ; Meiwen TANG
China Pharmacy 2025;36(21):2656-2661
OBJECTIVE To investigate the inhibitory effect and mechanism of Modified qifang weitong granules on gastric cancer based on in vitro and in vivo experiments. METHODS Human gastric cancer HGC-27 cells were divided into the following groups: control group (treated with fetal bovine serum), 10% drug-containing serum group, 15% drug-containing serum group, 20% drug-containing serum group, and 5-fluorouracil (5-Fu) group (positive control, 3.90 μg/mL). After culturing the cells in each group with the corresponding serum/drug solution, their proliferation, migratory and invasive abilities, as well as the cell cycle, were assessed. Additionally, the expression levels of epithelial-mesenchymal transition (EMT)-related proteins [E-cadherin, N-cadherin, and vimentin] in the cells were measured. Logarithmic-phase HGC-27 cells were harvested and subcutaneously injected into the right axillary region of nude mice to establish a subcutaneous xenograft tumor model in nude mice. The successfully modeled tumor-bearing nude mice were randomly divided into model group, low-, medium- and high-dose groups of Modified qifang weitong granules (17.65, 35.29 and 70.58 g/kg, respectively), and 5-Fu group (25 mg/kg), with 5 mice in each group. After 14 days of treatment with the corresponding drugs in each group, the histopathological morphology of the tumor tissues in the nude mice was observed. Immunohistochemistry and Western blot assay were employed to detect the expression levels of EMT- related proteins in the tumor tissues of the nude mice. RESULTS In the cell experiment, compared with the control group, the cell proliferation rate, migration rate, number of invasive cells, as well as the expression levels of N-cadherin and vimentin proteins, and the percentage of cells in the G2/M phase were all significantly decreased/reduced in the 15% drug-containing serum group, 20% drug-containing serum group (P<0.05). Conversely, the percentage of cells in the G0/G1 phase and the expression level of E- cadherin protein were significantly increased (P<0.05). In animal experiment, compared with the model group, the high-dose group of Modified qifang weitong granules exhibited significantly reduced tumor mass and expression levels of N-cadherin and vimentin proteins in the tumor tissues of nude mice (P<0.05), while the expression level of E-cadherinprotein in the tumor tissues was significantly increased (P<0.05). Additionally, the tumor cells varied in size and showed extensive necrosis. CONCLUSIONS Modified qifang weitong granules effectively inhibit gastric cancer in both in vitro and in vivo models, and the mechanism of action is related to the suppression of EMT.
5.Concept,Organizational Structure,and Medical Model of the Traditional Chinese Medicine Myocardial Infarction Unit
Jun LI ; Jialiang GAO ; Jie WANG ; Zhenpeng ZHANG ; Xinyuan WU ; Ji WU ; Zicong XIE ; Jingrun CUI ; Haoqiang HE ; Yuqing TAN ; Chunkun YANG
Journal of Traditional Chinese Medicine 2025;66(9):873-877
The traditional Chinese medicine (TCM) myocardial infarction (MI) unit is a standardized, regulated, and continuous integrated care unit guided by TCM theory and built upon existing chest pain centers or emergency care units. This unit emphasizes multidisciplinary collaboration and forms a restructured clinical entity without altering current departmental settings, offering comprehensive diagnostic and therapeutic services with full participation of TCM in the treatment of MI. Its core medical model is patient-centered and disease-focused, providing horizontally integrated TCM-based care across multiple specialties and vertically constructing a full-cycle treatment unit for MI, delivering prevention, treatment, and rehabilitation during the acute, stable, and recovery phases. Additionally, the unit establishes a TCM-featured education and prevention mechanism for MI to guide patients in proactive health management, reduce the incidence of myocardial infarction, and improve quality of life.
6.Study on the safety and pharmacological effect on improving dyspepsia of Shuangshu decoction in rats
Xinyuan CHEN ; Changzhou XIONG ; Jiongfen LI ; Kangyi YU ; Huan XU ; Yingxia WANG ; Dan LIAO ; Junyu TAO ; Ziyi YANG ; Caizhi LIN
China Pharmacy 2025;36(9):1059-1064
OBJECTIVE To study the safety of Shuangshu decoction in rats and its efficacy in improving functional dyspepsia (FD) in rats. METHODS In safety test, 40 rats were divided into blank control group, Shuangshu decoction low-dose, medium- dose and high-dose groups [108, 216, 324 g/(kg·d), calculated by raw medicine, the same applies below]; they were given relevant medicine intragastrically, for continuous 14 days. The mortality and toxic reactions of rats were recorded, and the organ indexes of the liver, kidney, spleen, lung and heart of rats were calculated; the pathological morphological changes in the liver, kidney, spleen, lung, heart, stomach, duodenum, and colon were observed to evaluate the acute toxicity of Shuangshu decoction. Another 40 rats were grouped and administered in the same way for 30 consecutive days. The mortality and toxic reactions of the rats were recorded, and the corresponding organ indexes were calculated. The pathological morphological changes in the corresponding organs were observed, and blood routine and serum biochemical indicators were measured, in order to assess the subacute toxicity of Shuangshu decoction. In pharmacodynamic experiments: 50 rats were divided into blank control group, model group, and Shuangshu decoction low-, medium-, and high-dose groups (9.45, 18.9, 37.8 g/kg), with 10 rats in each group. Except for blank control group, rats in all other groups were used to establish the FD rat model by subcutaneous injection of loperamide (3.5 mg/kg). Rats in each group were administered the corresponding drug solution/normal saline intragastrically, once a day, for 14 consecutive days. After the last medication, fecal moisture content, intestinal propulsion rate, gastric emptying rate and serum level of motilin were all detected, and interstitial cell of Cajal (ICC) ultrastructure of rats was observed in colon tissue. RESULTS The safety experiments showed that no death occurred in each dose group, and no significant difference was found in organ coefficient, routine blood and serum biological index, compared to blank control group (P>0.05); no abnormality was found in organ appearance and pathological sections. The results of the pharmacodynamic experiments showed that, compared with the blank control group, the fecal moisture content, gastric emptying rate, intestinal propulsion rate, and serum motilin levels in the model group were significantly decreased (P<0.05); in the colonic tissue, the mitochondria in the ICC exhibited severe swelling with the disappearance of cristae, and the endoplasmic reticulum was dilated. Compared with model group, the rats in Shuangshu decoction high-dose group showed significant increases in the above quantitative indicators (P< 0.05); additionally, there was a large number of mitochondria in the ICC of the colonic tissue, with clear cristae and regular arrangement. CONCLUSIONS Shuangshu decoction is safe and has a beneficial improving effect on FD rats; its mechanism of action may be related to the regulation of gastrointestinal hormone expression to promote gastric emptying and intestinal propulsion, as well as the repair of mitochondrial structure in ICCs to restore gastrointestinal function.
7.Effects of Modified Guomin Decoction (加味过敏煎) on Traditional Chinese Medicine Syndromes and Quality of Life in Patients with Mild to Moderate Atopic Dermatitis of Heart Fire and Spleen Deficiency Pattern:A Randomized,Double-Blind,Placebo-Controlled Trial
Jing NIE ; Rui PANG ; Lingjiao QIAN ; Hua SU ; Yuanwen LI ; Xinyuan WANG ; Jingxiao WANG ; Yi YANG ; Yunong WANG ; Yue LI ; Panpan ZHANG
Journal of Traditional Chinese Medicine 2025;66(10):1031-1037
ObjectiveTo observe the clinical efficacy and safety of Modified Guomin Decoction (加味过敏煎, MGD) in patients with mild to moderate atopic dermatitis (AD) of the traditional Chinese medicine (TCM) pattern of heart fire and spleen deficiency, and to explore its possible mechanisms. MethodsIn this randomized, double-blind, placebo-controlled study, 72 patients with mild to moderate AD and the TCM pattern of heart fire and spleen deficiency were randomly divided into a treatment group and a control group, with 36 cases in each group. The treatment group received oral MGD granules combined with topical vitamin E emulsion, while the control group received oral placebo granules combined with topical vitamin E treatment. Both groups were treated twice daily for 4 weeks. Clinical efficacy, TCM syndrome scores, Visual Analogue Scale (VAS) for pruritus, Dermatology Life Quality Index (DLQI) scores, Scoring Atopic Dermatitis (SCORAD) and serum biomarkers, including interleukin-33 (IL-33), interleukin-1β (IL-1β), immunoglobulin E (IgE), and tumor necrosis factor-α (TNF-α) were compared before and after treatment. Safety indexes was also assessed. ResultsThe total clinical effective rates were 77.78% (28/36) in the treatment group and 38.89% (14/36) in the control group, with cure rates of 19.44% (7/36) and 2.78% (1/36), respectively. The treatment group showed significantly better clinical outcomes compared to the control group (P<0.05). The treatment group exhibited significant reductions in total TCM syndrome scores, including erythema, edema, papules, scaling, lichenification, pruritus, irritability, insomnia, abdominal distension, and fatigue scores, as well as reductions in VAS, DLQI, SCORAD, and serum IgE and IL-33 levels (P<0.05 or P<0.01). Compared to the control group, the treatment group had significantly better improvements in all indicators except for insomnia (P<0.05). No adverse events occurred in either group. ConclusionMGD is effective and safe in treating mild to moderate AD patients with heart fire and spleen deficiency pattern. It significantly alleviates pruritus, improves TCM syndromes and quality of life, and enhances clinical efficacy, possibly through modulation of immune responses.
8.Impact factors of vascular heat sink effect during in vitro microwave ablation of porcine lung
Zenan CHEN ; Zhongliang ZHANG ; Sibin WANG ; Xinyuan GUO ; Jing ZHANG ; Xiaobo ZHANG ; Xiaofeng HE ; Liangliang MENG ; Xin ZHANG ; Yingtian WEI ; Yueyong XIAO ; Qun NAN ; Xiao ZHANG
Chinese Journal of Medical Imaging Technology 2025;41(3):383-388
Objective To observe the impact factors of vascular heat sink effect during in vitro microwave ablation(MWA)of porcine lung.Methods Simulation models were established using in vitro porcine lung tissue blocks based on isobaric inflation with an air pump and cyclic perfusion of duck blood with a glass tube and peristaltic pump,etc.MWA was performed under 8 different combining conditions(vessel diameter of 3 or 5 mm,blood perfusion of 30 or 50 cm/s,as well as distance between vessel and ablation antenna of 5 or 10 mm)each for 3 times.The highest temperature TV on vessel side and TC on control side during MWA,and ablation depth DV on vessel side and DC on control side after MWA were recorded.Multi-factor linear regression equations were constructed based on simulated vessel diameters,blood perfusion and distance between vessel and ablation antenna,and the impact factors of|TC-TV|and|DC-DV|were screened,respectively.Results Simulated vessel diameter showed linear positive correlation with both|TC-TV|and|DC-DV|(both P<0.001).Simulated distance between vessel and ablation antenna showed linear negative correlation with both|TC-TV|and|DC-DV|(both P<0.001),and the latter had more obvious impact on vascular heat sink effect than the former.Meanwhile,no significant linear relationship was found between simulated blood perfusion and|TC-TV|nor|DC-DV|(both P>0.05).Conclusion Simulated vessel diameter and distance between vessel and ablation antenna were both impact factors of vascular heat sink effect during in vitro MWA of porcine lung,and the latter was more influential,whereas simulated blood perfusion showed no significant impact on it.
9.Cortical activation during obstacle avoidance in convalesent stroke patients:A fNIRS study
Jiay-an MAO ; Xinyuan WANG ; Wenbing LIU
Chinese Journal of Rehabilitation Medicine 2025;40(3):382-388
Objective:To explore cortical activation during the obstacle avoidance task in convalescent stroke patients,and examine the effect of obstacle avoidance difficulty on brain activation.Method:A total of 20 convalescent stroke patients were recruited to perform various motor tasks,including walking,simple obstacle avoidance,difficult obstacle avoidance,and motor imagery.Functional near-infrared spectroscopy(fNIRS)was used to detect the oxygenated hemoglobin concentration in the prefrontal cortex(PFC),premotor cortex(PMC)and supplementary motor area(SMA)of the patients.Additional relevant sec-ondary indicators were evaluated and collected.Statistical analysis was performed without grouping and with grouping.Result:The activation levels of bilateral PFC,PMC and SMA during the dynamic task were significantly dif-ferent from those during the static tasks(P<0.05),with the highest activation observed in the PFC.There were significant differences between simple and difficult obstacle avoidance tasks in the unaffected-side SMA(P<0.05).In addition,there was a linear positive correlation between the peak activation level of PMC on the unaffected side and Tinetti score(P<0.05).Conclusion:Bilateral PFC,PMC and SMA are involved in limb movement in convalescent stroke patients,with PFC showing the highest level of activation.In addition,SMA on the unaffected side may contribute to regulating the difficulty of obstacle avoidance.Moreover,the peak activation level of PMC on the unaffected side is associated with balance and walking function.
10.Early effectiveness of posterior 180-degree decompression via unilateral biportal endoscopy in treatment of lumbar spinal stenosis combined with MSU-1 lumbar disc herniation.
Feiyu ZHAO ; Xiaoting QIU ; Jie YUAN ; Ruxing LIU ; Xinyuan WEI ; Wei ZHAO ; Yongfeng WANG
Chinese Journal of Reparative and Reconstructive Surgery 2025;39(6):735-740
OBJECTIVE:
To evaluate early effectiveness of posterior 180-degree decompression via unilateral biportal endoscopy (UBE) in the treatment of lumbar spinal stenosis (LSS) combined with Michigan State University (MSU)-1 lumbar disc herniation (LDH).
METHODS:
A retrospective analysis was conducted on clinical data from 33 patients with LSS combined with MSU-1 LDH, who met selection criteria and were treated between March 2022 and January 2024. All patients underwent UBE-assisted 180-degree spinal canal decompression. The cohort comprised 17 males and 16 females, aged 37-82 years (mean, 67.1 years). Preoperative presentations included bilateral lower limbs intermittent claudication and radiating pain, with disease duration ranging from 5 to 13 months (mean, 8.5 months). Affected segments included L 3, 4 in 4 cases, L 4, 5 in 28 cases, and L 5, S 1 in 1 case. LSS was rated as Schizas grade A in 4 cases, grade B in 5 cases, grade C in 13 cases, and grade D in 11 cases. LDH was categorized as MSU-1A in 24 cases, MSU-1B in 2 cases, and MSU-1AB in 7 cases. Intraoperative parameters (operation time, blood loss) and postoperative hospitalization length were recorded. The visual analogue scale (VAS) score and Oswestry Disability Index (ODI) were used to assess the lower limb pain and functional outcomes after operation. Clinical efficacy was evaluated at last follow-up via modified MacNab criteria. Quantitative radiological assessments included dural sac cross-sectional area (DSCA) measurements and spinal stenosis grading on lumbar MRI. Morphological classification of lumbar canal stenosis was determined according to the Schizas grading, categorized into four grades.
RESULTS:
The operation time was 60.4-90.8 minutes (mean, 80.3 minutes) and intraoperative blood loss was 13-47 mL (mean, 29.9 mL). The postoperative hospitalization length was 3-5 days (mean, 3.8 days). All patients were followed up 12-16 months (mean, 13.8 months). The VAS score and ODI improved at immediate and 3, 6, and 12 months after operation compared to before operation, and the differences between different time points were significant ( P<0.05). At last follow-up, the clinical efficacy assessed by the modified MacNab criteria were graded as excellent in 23 cases, good in 9 cases, and poor in 1 case, with an excellent and good rate of 96.97%. Postoperative lumbar MRI revealed the significant decompression of the dural sac in 32 cases, with 1 case showing inadequate dural expansion. DSCA measurements confirmed progressive enlargement and stenosis reduction over time. The differences were significant ( P<0.05) before operation, immediately after operation, and at 6 months after operation. At 6 months after operation, Schizas grading of spinal stenosis improved to grade A in 27 cases and grade B in 6 cases.
CONCLUSION
Posterior 180-degree decompression via UBE is a safe and feasible strategy for treating LSS combined with MSU-1 LDH, achieving effective neural decompression while preserving intervertebral disc integrity.
Humans
;
Spinal Stenosis/diagnostic imaging*
;
Male
;
Female
;
Aged
;
Lumbar Vertebrae/surgery*
;
Middle Aged
;
Intervertebral Disc Displacement/complications*
;
Decompression, Surgical/methods*
;
Retrospective Studies
;
Endoscopy/methods*
;
Adult
;
Aged, 80 and over
;
Treatment Outcome


Result Analysis
Print
Save
E-mail